Search by Drug Name or NDC

    NDC 50090-1219-01 Lisinopril and Hydrochlorothiazide 25; 20 mg/1; mg/1 Details

    Lisinopril and Hydrochlorothiazide 25; 20 mg/1; mg/1

    Lisinopril and Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is HYDROCHLOROTHIAZIDE; LISINOPRIL.

    Product Information

    NDC 50090-1219
    Product ID 50090-1219_24e3d307-f471-4130-a9e5-25d1db7c47ee
    Associated GPIs 36991802550320
    GCN Sequence Number 000389
    GCN Sequence Number Description lisinopril/hydrochlorothiazide TABLET 20 MG-25MG ORAL
    HIC3 A4J
    HIC3 Description ACE INHIBITOR-THIAZIDE OR THIAZIDE-LIKE DIURETIC
    GCN 88001
    HICL Sequence Number 000131
    HICL Sequence Number Description LISINOPRIL/HYDROCHLOROTHIAZIDE
    Brand/Generic Generic
    Proprietary Name Lisinopril and Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lisinopril and Hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 25; 20
    Active Ingredient Units mg/1; mg/1
    Substance Name HYDROCHLOROTHIAZIDE; LISINOPRIL
    Labeler Name A-S Medication Solutions
    Pharmaceutical Class Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076194
    Listing Certified Through 2024-12-31

    Package

    NDC 50090-1219-01 (50090121901)

    NDC Package Code 50090-1219-1
    Billing NDC 50090121901
    Package 100 TABLET in 1 BOTTLE (50090-1219-1)
    Marketing Start Date 2014-11-28
    NDC Exclude Flag N
    Pricing Information N/A